Promoter holding
64.27%
PP
Panjon Pharma Limited - Due diligence report
A 360° intelligence report on Panjon Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress …
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Panjon Pharma Limited — 360° Intelligence Report
Generated from MCA filings & public records49/100
Trust Score
Caution Indicated
Panjon Pharma Limited is assessed as Caution Indicated with a Trust Score of 49/100. Panjon Pharma Limited is an active public limited indian non-government company incorporated in 1994, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and an unassessed financial risk profile.
Report generated on 09 Oct 2026 from the latest processed filings. Panjon Pharma Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreCaution Indicated
49/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
11/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
No processed financialsFinancial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: N/A No Data
- Financial statements needed for a credit view.
Charges position: 5 open (14.07 cr) · 0 satisfied (-).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Punjab National Bank | 3 | 48.0 cr |
| State Bank Of India | 1 | 48.0 cr |
| Icici Bank Limited | 1 | 48.0 cr |
Compliance Score: 11/100 Caution Indicated
- Company status is Active as per MCA.
- Marked ACTIVE non-compliant (INC-22A).
- Last balance sheet is for Mar 2010 - filings overdue.
- Flagged by authority: BANKS, MCA.
- Litigation present in 2 court forum(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 55/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| KIRTI KUMAR SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MANOJ KOTHARI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ANJU M KOTHARI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- KIRTI KUMAR SHAH has DIN status "Disqualified by RoC u/s 164(2)".
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
06
Ownership & Group Intelligence
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Key managerial personnel: MANOJ KOTHARI (Managing Director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth N/A · Distress 80
Growth signals & trust indicators
Operating for 31+ years.
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
Statutory filings appear overdue.
Compliance score is weak (11/100).
5 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence43/100
Caution indicated
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- No financials on record - ask for audited statements.
Banker assessment18/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- No filed financials - rely on banking statements and GST data.
- 5 open charge(s) of 14.07 cr already registered.
- Compliance gaps should be priced into terms.
Investor view29/100
Limited indicators at present
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Request management accounts - public filings insufficient.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 11 events30 Sep 2010
Last AGM held
Annual general meeting
31 Mar 2010
Latest balance sheet
Filed with ROC
20 Mar 2007
Charge created
Icici Bank Limited - 47.24 Lakh
31 Jan 2007
Charge created
Punjab National Bank - 5.60 cr
17 Dec 2004
Charge created
State Bank Of India - 2.00 cr
04 Jun 2003
Charge created
Punjab National Bank - 4.50 cr
Charge created
Punjab National Bank - 1.50 cr
18 Jul 2002
Director appointed
KIRTI KUMAR SHAH (Director)
12 May 1999
Director appointed
ANJU M KOTHARI (Director)
12 Oct 1994
Incorporated
Registered with Roc Gwalior
Director appointed
MANOJ KOTHARI (Managing Director)
10
Key Observations
Auto-generated from the data above3 active director(s) / partner(s); review board churn before relying on management continuity.
| Company | CIN | Location |
|---|---|---|
| Brilliant Institute Of Professional Studies Private Limited | U80904MP2009PTC022210 | - |
| Ajmera Pharmacos Private Limited | U24230MP2008PTC021164 | - |
| MOHAN COMPOSITE PANEL LLP | AAO-8408 | - |
| Wide Vision Technologies Limited | U65921MP1997PLC011881 | - |
| Prestige Corporate Consultants Private Limited | U74140MP1994PTC008379 | - |
| Kalyan India Infrastructure Private Limited | U45209MP2008PTC020582 | - |
| M.P.Audyogik Kendra Vikas Nigam (Indore) Ltd | U45203MP1981SGC001850 | - |
| Shloak Warehousing Private Limited | U63020MP2014PTC032458 | - |
| Enlightning Multitrade Private Limited | U51900MP2011PTC027117 | - |
| Ashiyana Realty And Developers Private Limited | U45203MP1997PTC012094 | - |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Panjon Pharma Limited before audits and certifications: compliance score 11/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Panjon Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Panjon Pharma Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Caution indicated. Trust score 49/100, distress signals and MSME payment-delay disclosures - know whether Panjon Pharma Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Panjon Pharma Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Panjon Pharma Limited an active company?
Panjon Pharma Limited has MCA status “Active” with a compliance score of 11/100 (Caution Indicated).
Is Panjon Pharma Limited financially healthy?
Processed financial statements are not yet available for Panjon Pharma Limited, so its financial health is unassessed.
Should I do business with Panjon Pharma Limited?
Its overall Trust Score is 49/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Panjon Pharma Limited?
See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.
Does Panjon Pharma Limited have loans or charges against its assets?
5 open charge(s) are registered against its assets.
Is Panjon Pharma Limited up to date with its ROC filings?
Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 11/100 (Caution Indicated).
Is it risky to lend to Panjon Pharma Limited?
Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
